Avanos Medical Inc (AVNS)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -403,300 | 26,100 | 14,000 | 2,700 | 800 | 15,800 | 34,400 | 56,000 | 64,300 | 64,700 | 51,600 | 26,900 | 5,800 | -65,900 | -73,000 | -70,700 | -60,500 | -19,600 | -35,700 | -41,100 |
| Revenue (ttm) | US$ in thousands | 687,800 | 681,500 | 682,400 | 680,100 | 705,700 | 749,900 | 780,700 | 814,300 | 820,000 | 795,900 | 777,900 | 761,300 | 744,600 | 736,200 | 737,800 | 715,100 | 714,800 | 719,600 | 705,300 | 713,800 |
| Pretax margin | -58.64% | 3.83% | 2.05% | 0.40% | 0.11% | 2.11% | 4.41% | 6.88% | 7.84% | 8.13% | 6.63% | 3.53% | 0.78% | -8.95% | -9.89% | -9.89% | -8.46% | -2.72% | -5.06% | -5.76% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-403,300K ÷ $687,800K
= -58.64%
The pretax margin of Avanos Medical Inc has shown a significant improvement over the quarters, starting from negative percentages in early 2020 and reaching positive percentages by the end of 2022. Although there was a sharp increase in pretax margin to 8.13% in September 2022, it slightly declined to 7.84% by the end of December 2022. The pretax margin continued to show positive growth into 2024, with percentages ranging from 0.40% to 3.83% until September 30, 2024. However, there was a notable decline in the pretax margin to -58.64% by December 31, 2024, indicating a significant decrease in profitability for that period. It is essential for Avanos Medical Inc to analyze and address the factors contributing to this sharp decline to sustain profitability in future quarters.
Peer comparison
Dec 31, 2024